North Brunswick, NJ · Founded 2020 · Privately Held (backing)
Developer of a precision exposome medicine platform designed to analyze the molecular impact of environmental exposures on health. LinusBio is based in North Brunswick, NJ and was founded in 2020. Its last reported valuation was $171 million in Jul 2024. It has raised $34.6 million.
Last reported valuation
$171.2M
Oct 2026
Priced at
—
Total raised
$34.6M
Last round
—
Cap table — not yet on record
LinusBio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of LinusBio with a free account
·Watch LinusBio: the Monday email on marks, rounds and moves
